La Jolla Pharma (LJPC) PT Lowered to $15 at Chardan Capital Markets
Tweet Send to a Friend
Chardan Capital Markets analyst Keay Nakae lowered the price target on La Jolla Pharma (NASDAQ: LJPC) to $15.00 (from $20.00) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
